M. Walles et al., Verapamil metabolism in distinct regions of the heart and in cultures of cardiomyocytes of adult rats, DRUG META D, 29(5), 2001, pp. 761-768
A substantial number of drugs act either directly or indirectly on the hear
t, but surprisingly, little is known about drug oxidation in the heart. We
therefore investigated the metabolism of the calcium antagonist verapamil i
n microsomal fractions isolated from the left and right ventricle of heart
muscle and in primary cultures of cardiomyocytes of adult rats. Metabolism
of verapamil proceeded predominantly with microsomal fractions isolated fro
m the right ventricle of rat heart, and in liquid chromatographic-tandem ma
ss spectrometry (LC-MS/MS) and LC-MS3 experiments four metabolites (M1-M4)
could be identified. Furthermore, the intermediate biotransformation produc
ts M5 to M8 could additionally be identified in cultures of primary cardiom
yocytes, thus providing new insight into the mechanisms of the N-dealkylati
on and O-demethylation pathway of verapamil. We show metabolism of verapami
l to be predominant in the right ventricle of the heart, and the data repor
ted herein may explain metabolic inactivation and/or adverse drug reactions
of certain cardiovascular drugs on the basis of tissue specific metabolism
.